Suppr超能文献

噬菌体尾刺蛋白可用于检测假氨基糖酸涂层的致病性细菌,并指导具有跨物种抗菌活性的抗聚糖抗体的开发。

Bacteriophage Tail-Spike Proteins Enable Detection of Pseudaminic-Acid-Coated Pathogenic Bacteria and Guide the Development of Antiglycan Antibodies with Cross-Species Antibacterial Activity.

机构信息

Institute of Biological Chemistry, Academia Sinica, Taipei 115, Taiwan.

Department of Chemistry, National Taiwan University, Taipei 106, Taiwan.

出版信息

J Am Chem Soc. 2020 Nov 18;142(46):19446-19450. doi: 10.1021/jacs.0c07314. Epub 2020 Nov 9.

Abstract

Pseudaminic acid (Pse), a unique carbohydrate in surface-associated glycans of pathogenic bacteria, has pivotal roles in virulence. Owing to its significant antigenicity and absence in mammals, Pse is considered an attractive target for vaccination or antibody-based therapies against bacterial infections. However, a specific and universal probe for Pse, which could also be used in immunotherapy, has not been reported. In a prior study, we used a tail spike protein from a bacteriophage (ΦAB6TSP) that digests Pse-containing exopolysaccharide (EPS) from strain 54149 (-54149) to form a glycoconjugate for preparing anti--54149 EPS serum. We report here that a catalytically inactive ΦAB6TSP (I-ΦAB6TSP) retains binding ability toward Pse. In addition, an I-ΦAB6TSP-DyLight-650 conjugate (Dy-I-ΦAB6TSP) was more sensitive in detecting -54149 than an antibody purified from anti- -54149 EPS serum. Dy-I-ΦAB6TSP also cross-reacted with other pathogenic bacteria containing Pse on their surface polysaccharides (., and ), revealing it to be a promising probe for detecting Pse across bacterial species. We also developed a detection method that employs I-ΦAB6TSP immobilized on microtiter plate. These results suggested that the anti--54149 EPS serum would exhibit cross-reactivity to Pse on other organisms. When this was tested, this serum facilitated complement-mediated killing of and , indicating its potential as a cross-species antibacterial agent. This work opens new avenues for diagnosis and treatment of multidrug resistant (MDR) bacterial infections.

摘要

假酸寡糖(Pse)是一种存在于致病菌表面相关聚糖中的独特碳水化合物,在毒力中起着关键作用。由于其显著的抗原性和在哺乳动物中不存在,Pse 被认为是针对细菌感染的疫苗或基于抗体的治疗的有吸引力的靶标。然而,尚未报道针对 Pse 的特异性和通用探针,该探针也可用于免疫疗法。在之前的研究中,我们使用了一种来自噬菌体(ΦAB6TSP)的尾刺蛋白,该蛋白消化来自 54149 株(-54149)的含有 Pse 的胞外多糖(EPS),以形成糖缀合物来制备针对 -54149 EPS 的抗血清。我们在此报告称,一种催化失活的 ΦAB6TSP(I-ΦAB6TSP)保留了与 Pse 的结合能力。此外,与从抗 -54149 EPS 血清中纯化的抗体相比,I-ΦAB6TSP-DyLight-650 缀合物(Dy-I-ΦAB6TSP)更敏感地检测到 -54149。Dy-I-ΦAB6TSP 还与其他在其表面多糖上含有 Pse 的致病性细菌(例如, 和 )发生交叉反应,表明它是一种有前途的跨细菌物种检测 Pse 的探针。我们还开发了一种使用固定在微量滴定板上的 I-ΦAB6TSP 的检测方法。这些结果表明,抗 -54149 EPS 血清将对其他生物体上的 Pse 表现出交叉反应性。当对此进行测试时,该血清促进了补体介导的 和 的杀伤,表明其作为一种跨物种抗菌剂的潜力。这项工作为诊断和治疗多药耐药(MDR)细菌感染开辟了新途径。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验